Answers are grounded in this paper and cite their sources.
Cohort study examines treatment patterns of bone-modifying agents in men with metastatic castration-resistant prostate cancer, indicating important trends.
This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.
No takes yet. Share an insight, caveat, or question.
Özay et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: